Clinical Trials

Accrual Status
Limit to SWOG Trials

654 Results

Active Filters

Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0727
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0518

Phase III Prospective Randomized Comparison of Depot Octreotide plus Interferon Alpha versus Depot Octreotide plus Bevacizumab (NSC #704865) in Advanced, Poor Prognosis Carcinoid Patients

Research Committee(s)
Gastrointestinal Cancer
Activated
12-01-2007
Closed
09-01-2012
ClinicalTrials.gov Registry Number
NCT00569127
Closed
Phase
Accrual
91%
Published
Closed
Phase
Accrual
11%
Published
Closed
Phase
Accrual
19%
Published
SWOG Clinical Trial Number
S0521
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0354
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0622
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0353
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0530
Closed
Phase
Accrual
100%
Published
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0528

Phase I Study Evaluating the Combination of Lapatinib (GW572016; NSC-727989; IND-75,093) and Everolimus (RAD001; NSC-733504; IND-75,093) in Patients with Advanced Solid Tumors

Research Committee(s)
Early Therapeutics & Rare Cancers
Activated
09-01-2006
Closed
08-25-2009
ClinicalTrials.gov Registry Number
NCT00352443
Closed
Phase
Accrual
99%
Published
SWOG Clinical Trial Number
S0421
Closed
Phase
Accrual
100%
Published
Closed
Phase
Accrual
100%
Published
Closed
Phase
Accrual
25%
Published
SWOG Clinical Trial Number
S0526

Phase II Trial of Pemetrexed in Patients with Selected Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)

Research Committee(s)
Lung Cancer
Activated
07-01-2006
Closed
10-01-2008
Closed
Phase
Accrual
91%
Published
Closed
Phase
Accrual
95%
Published
SWOG Clinical Trial Number
S0618
Closed
Phase
Accrual
40%
Published
SWOG Clinical Trial Number
S0429
Closed
Phase
Accrual
58%
Published
SWOG Clinical Trial Number
S0434